Name
pvdl2
Label
Peripheral Vasodilators, Exclude Dipyridamole (SHHS2)
Description

Participant taking PERIPHERAL VASODILATORS, EXCLUDE DIPYRIDAMOLE within two weeks of the SHHS2 visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Domain
noyes01
  • 0: No
  • 1: Yes
  • 8: Don't know
Type
choices
Peripheral Vasodilators, Exclude Dipyridamole (SHHS2) vs SHHS Visit Number
Visit 1 Interim Follow-up Visit Visit 2 CVD Outcomes
Total - - 4,080 -
No - - 3,618 -
Yes - - 2 -
Don't know - - - -
Unknown - - 460 -
Peripheral Vasodilators, Exclude Dipyridamole (SHHS2) vs Age at SHHS1
Visit 2
35-44 years 45-54 years 55-64 years 65-74 years 75-84 years 85 years or older Total
Total 184 707 1,321 1,200 624 44 4,080
No 176 647 1,147 1,055 553 40 3,618
Yes - - 1 1 - - 2
Don't know - - - - - - -
Unknown 8 60 173 144 71 4 460
Peripheral Vasodilators, Exclude Dipyridamole (SHHS2) vs Gender
Visit 2
Male Female Total
Total 1,861 2,219 4,080
No 1,660 1,958 3,618
Yes 1 1 2
Don't know - - -
Unknown 200 260 460
Peripheral Vasodilators, Exclude Dipyridamole (SHHS2) vs Race
Visit 2
White Black Other Total
Total 3,587 256 237 4,080
No 3,160 242 216 3,618
Yes 2 - - 2
Don't know - - - -
Unknown 425 14 21 460